Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-12-08, Stock:LLY, The news for the past five days is as follows:
2020-12-01: NEWS1: Activist Shareholders Press Pfizer, J&J, and Other Pharma Companies on Covid Vaccine Price and Access.
2020-12-02: NEWS1: Lilly announces 650,000 additional doses of neutralizing antibody bamlanivimab (LY-CoV555) purchased by U.S. government to treat COVID-19.NEWS2: ‘The pandemic isn’t over’ just because we have vaccines: Dr. Craig Spencer.NEWS3: CVS pilots giving Eli Lilly's COVID-19 antibody drug at patient's home.
2020-12-03: NEWS1: Coronavirus update: US reaches 100K hospitalization record; federal gov't buys more Eli Lilly antibody doses.NEWS2: The Daily Biotech Pulse: Lilly Secures Additional Orders For COVID-19 Antibody Treatment, Decision Day For BioCryst, Kinnate Biopharma To Make Wall Street Debut.NEWS3: Lilly (LLY) to Supply More Doses of COVID-19 Antibody to US.
2020-12-04: NEWS1: The biggest challenges facing vaccine distribution.NEWS2: Why BioCryst, Moderna And More Are Moving Today.NEWS3: Coronavirus update: Fauci to become Biden's chief medical adviser; United Health Group to study Eli Lilly antibody.NEWS4: Eli Lilly Rises on New Trial to Treat Covid in High-Risk Patients.NEWS5: Vaccines and Approved Antibodies Dim Vir Biotechnology’s Covid Opportunity, Analyst Says.NEWS6: Pharma Stock Roundup: Approval of PFE/BNTX Coronavirus Vaccine in UK, Other Updates.NEWS7: Lilly and UnitedHealth Group partner on pragmatic study of neutralizing antibody bamlanivimab (LY-CoV555) for COVID-19.NEWS8: Lilly and UnitedHealth launch trial of COVID-19 antibody.
2020-12-07: NEWS1: Loxo Oncology at Lilly Announces Updated Data from the Phase 1/2 BRUIN Clinical Trial for LOXO-305 in Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma at the American Society of Hematology Annual Meeting.NEWS2: Lilly (LLY)/UnitedHealth Launch COVID-19 Study on Bamlanivimab.NEWS3: AbCellera Biologics sets terms of IPO, which could value the company at up to $4.5 billion.NEWS4: Thiel-backed therapy developer AbCellera looks to raise up to $391 mln in IPO.

Answer: Rise